minocycline hydrochloride · Epi Hlth · NDA 209269
Minolira
Earliest generic entry, as listed · earliest of 2 marketed strengths
7 Apr 2036
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 11103517.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11103517 | drug product · sets the listed date | 7 Apr 2036 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 209269 · 001 · discontinued | tablet, extended release, oral | EQ 105MG BASE | 7 Apr 2036 |
| 209269 · 002 · discontinued | tablet, extended release, oral | EQ 135MG BASE | 7 Apr 2036 |